Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

102.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Expert Ratings For Abbott Laboratories
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: 
Via Benzinga
Podcast: How to Find Support When You're Studying STEM
SOURCE: Abbott 
Via 3BL Media
Quipt Reaches Significant Milestone with Fresh Acquisition and Announces new EVP of Operations
Photo by Marcelo Leal on Unsplash Quipt Home Medical Corp. (NASDAQ: QIPT; TSXV: QIPT) announced that it has recently acquired a business with operations in Mississippi, reporting... 
Via Benzinga
Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock
BioSig Technologies, Inc. (NASDAQ: BSGM) announced that an article titled "Evaluation of a Novel Cardiac Signal Processing System for Electrophysiology Procedures: The PURE EP 2.0... 
Via Benzinga
Cramer Recommends To Hold Doximity, Avoid This Industry And Buy This Stock
On CNBC’s “Mad Money... 
Via Benzinga
Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner
Via Investor Brand Network
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option... 
Via Benzinga
Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters
In recent weeks, an increase in demand for COVID-19 tests from U.S. employers has deepened the shortage of rapid tests and is driving up testing programs costs. What Happened: The... 
Via Benzinga
Exposures COVID-19
Abbott: No One-Trick Pony
I recommend you add a diversified healthcare company to your portfolio: Abbott Laboratories. The Chicago-based firm offers medical testing, medical devices, pharmaceuticals, nutritional products, and... 
Via Talk Markets
Abbott Commits to Reducing Malnutrition Globally With Launch of Abbott Center for Malnutrition Solutions
SOURCE: Abbott 
Via 3BL Media
Exposures COVID-19
2 Unstoppable Stocks to Buy and Hold Forever
Both companies have historically performed much better than the broader market. 
Via The Motley Fool
FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants
The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage... 
Via Benzinga
Exposures Product Safety
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
Via FinancialNewsMedia
Exposures COVID-19
Stocks Going Ex Dividend In October 2021
Here is a short list of some of the many stocks going ex dividend during the next month. 
Via Talk Markets
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
Via FinancialNewsMedia
As Variants Spread, Self-Reporting Can Provide Solace
SOURCE: Abbott 
Via 3BL Media
Exposures COVID-19 Product Safety
FDA Warns On Potential False Positive Results With Abbott's COVID-19 Tests
The FDA has issued a letter to healthcare professionals alerting them to the potential for false-positive results with Abbott Laboratories (NYSE: ABT) two COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
3 Top Growth Stocks You Can Buy and Hold Forever
There will be no need to check on how they're doing every day. 
Via The Motley Fool
Kids Back to School? Our Tech Can Help Ease Your Mind
SOURCE: Abbott 
Via 3BL Media
Exposures COVID-19 Product Safety
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
Via FinancialNewsMedia
Exposures COVID-19
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
Notable Abbott Laboratories Insider Trades $4.14 Million In Company Stock
Michael J Pederson, Senior Vice President at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on September 8, according to a new SEC filing. What... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Got $3,000? Keep It Safe With These 3 Healthcare Stocks
They offer products that their customers absolutely can't do without, and they also pay dividends. 
Via The Motley Fool
3 Dividend Stocks to Buy and Hold Forever
They all have solid dividends plus attractive growth prospects. 
Via The Motley Fool
Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 mi... 
Via Benzinga
Exposures COVID-19
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.